Skip Header

5 results for author:"Lyttle C.R." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (3)

Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.

Zhang Z., Olland A.M., Zhu Y., Cohen J., Berrodin T., Chippari S., Appavu C., Li S., Wilhem J., Chopra R. et al.

J. Biol. Chem. 280:28468-28475(2005) · UniProtKB (1)

A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis.

Harris H.A., Bruner-Tran K.L., Zhang X., Osteen K.G., Lyttle C.R.

Hum. Reprod. 20:936-941(2005) · Mapped (8)

Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.

Stossi F., Barnett D.H., Frasor J., Komm B., Lyttle C.R., Katzenellenbogen B.S.

Endocrinology 145:3473-3486(2004) · Mapped (58)

Estrogen regulation of tissue-specific expression of complement C3.

Sundstrom S.A., Komm B.S., Ponce-De-Leon H., Yi Z., Teuscher C., Lyttle C.R.

J. Biol. Chem. 264:16941-16947(1989) · UniProtKB (1)

Regulation of alpha 2(I), alpha 1(III), and alpha 2(V) collagen mRNAs by estradiol in the immature rat uterus.

Frankel F.R., Hsu C.-Y.J., Meyers J.C., Lin E., Lyttle C.R., Komm B., Mohn K.

DNA 7:347-354(1988) · UniProtKB (1)

to top of page·

Page 1 of 1